about
Aberrant muscle antigen exposure in mice is sufficient to cause myositis in a Treg cell-deficient milieuTelomere length and regulatory proteins in human skeletal muscle with and without ongoing regenerative cycles.An overview of polymyositis and dermatomyositis.Diagnostic value of markers of muscle degeneration in sporadic inclusion body myositis.Evaluation and management of polymyositis.Expression of myogenic regulatory factors and myo-endothelial remodeling in sporadic inclusion body myositisA case of polymyositis associated with papillary thyroid cancer: a case report.Myositis-specific and myositis-associated autoantibody profiles and their clinical associations in a large series of patients with polymyositis and dermatomyositisProximal myopathy: diagnostic approach and initial management.The relevance of applying exercise training principles when designing therapeutic interventions for patients with inflammatory myopathies: a systematic review.Cricopharyngeal myotomy for primary cricopharyngeal dysfunction caused by a structural abnormality localized in the cricopharyngeus muscle: report of a case.Pregnancy outcomes in dermatomyositis and polymyositis patients.Analysis of sexual function of patients with dermatomyositis and polymyositis through self-administered questionnaires: a cross-sectional study.Role of Positron Emission Tomography-computed Tomography in a Case of Suspected Paraneoplastic Inflammatory Polymyositis with Urinary Bladder Tumor.Reduced ovarian reserve in patients with adult polymyositis.Manual muscle testing and hand-held dynamometry in people with inflammatory myopathy: An intra- and interrater reliability and validity study.
P2860
Q33661671-8E052F8C-B56F-45A1-805D-FBF89FC2FC82Q34172479-2270C464-8CB7-4781-8264-62C6BA3BE130Q34667765-F5EABC00-F523-472D-AE1C-D745AC8F9688Q35607479-66150493-AFED-40D2-9804-EF4C9A3911F0Q36352335-B20442BC-EE7B-416E-A260-B02752CDF911Q36575286-CE9286A4-ABFF-488E-AC1E-3C874BC49E59Q36975362-136A397A-9BB7-4595-A5B7-080AAD58F49AQ37023594-34B44FB0-F4A9-4E20-8EDF-5B5BF32F51CDQ38099824-FAF7C94D-D500-4E82-94F9-1E5880A038FEQ38566211-5F2207DF-1FBB-4C56-AE83-69A538FA9737Q39260339-62D3B36B-312A-4495-804D-4683B9B0C751Q41596525-796A2890-D551-4F84-84E9-3CE6EB48BDFDQ47941686-7663D9B4-DAA2-4CE8-996B-FC135BE2FE4AQ49696094-E70C0E06-A2AD-4E0E-9CAE-40C1746DC13AQ50794260-15EC3AA3-C767-4DB1-BDDF-D2B85776292BQ55078313-DF64CE3B-A299-49B8-A4B2-0E3DE0C63145
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Inflammatory myopathies: evaluation and management.
@en
Inflammatory myopathies: evaluation and management.
@nl
type
label
Inflammatory myopathies: evaluation and management.
@en
Inflammatory myopathies: evaluation and management.
@nl
prefLabel
Inflammatory myopathies: evaluation and management.
@en
Inflammatory myopathies: evaluation and management.
@nl
P356
P1476
Inflammatory myopathies: evaluation and management.
@en
P2093
Steven A Greenberg
P304
P356
10.1055/S-2008-1062267
P577
2008-04-01T00:00:00Z